Non-cardiac Chest Pain
9
1
2
4
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 77/100
22.2%
2 terminated out of 9 trials
66.7%
-19.8% vs benchmark
11%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
One-hoUr Troponin Using a High-sensitivity Point-Of-Care Assay in Emergency Primary Care
iCBT for Cardiac Anxiety in Patients With NCCP
Internet-delivered CBT for Patients With NCCP
Validation of the Panic Screening Score in Patient With Unexplained Chest Pain
Treatment Study Comparing Manual Treatment or Advice in Acute, Musculoskeletal Chest Pain
Non-cardiac Chest Pain Evaluation and Treatment Study (CARPA) - Part 1: Diagnosis.
Evaluation of Patients With Non-cardiac Chest Pain
The Role of Visceral Hyperalgesia, Gastroesophageal Reflux Disease (GERD) and Esophageal Motility Disorder (EMD) in NCCP Patients
Effect of GABAB Agonist on Visceral Hyperalgesia in NCCP patientsChinese?